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ABSTRACT 
Alzheimer‟s disease (AD) is a chronic and progressive neurodegenerative disease .An 
important approach for treating AD is the inhibition of acetylcholine esterase (AChE) and 
Monoacylglyceride Lipase (MAGL). Many of the medicinal plants have suggested for 
treatment of Alzheimer. But only few plants only proved for their Anti-Alzheimeric potential. 
One such herb is Bacopa monnieri. . Bacosides are most active constituents of Bacopa 
monnieri. Bacoside A , mostly reported herbal drug- a mixture of four triglycosidic saponins, 
namely bacoside A3, bacopaside II, bacopasaponin C and the jujubogenin isomer. Its 
inhibiting potential were analysed by molecular docking. It is having very low binding energy 
of -20.1 kcal/mol and -12.7 kcal/mol on the targets AChE and MAGL respectively. The 
druglikeness and toxicity were predicted with ADMET predictor tools namely molinspiration 
and protox respectively. Bacoside comes under class IV toxicity. This project related to the 
production of Bacoside A in Callus Cultures of Bacopa monnieri and its enhancements 
through Elicitation. Elicitor may be defined as a substance which, when introduced in small 
concentrations to a living cell system, initiates or improves the biosynthesis of specific 
compounds. Callus of Bacopa monnieri was efficiently induced by 0.5mg/l of NAA. 
supplement of Auxins IAA was not much efficient in callus induction. Cytokinin BAP was 
used to inhibit the root formation. The developed fried callus was used for suspension culture 
under optimised parameters. The suspension cultures were treated under the influence of the 
Elicitors. HPLC was used for estimation of Bacoside A.  
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CHAPTER 1 
INTRODUCTION 
Alzheimer‘s disease (AD) is a progressive neurodegenerative disease associated 
with memory loss, and thinking impairment (Johnson et al., 2000). The Characteristics of 
Alzheimer include alterations in the brain, such as the accumulation of β-amyloid plaques 
and neurofibrillary tangles. An important strategy to treat AD is the inhibition of 
acetylcholine esterase (AChE) and Monoacyl Glyceride Lipase (MAGL). Memory 
enhancement and reduction of beta amyloids are the other factors for treatment of AD. 
AChE and Monoacyl Glyceride lipase are being the targets for the drugs for Alzheimer. 
Acetylcholinesterase (AChE) is the enzyme which catalyses the breakdown of 
Acetylcholine which is an important neurotransmitter. The enzyme AChE needs to be 
inhibited to prolong the occurrence of Acetylcholine. Monoacyl Glyceride Lipase is the 
enzyme which hydrolysis the triglycerides to fatty acids and glycerol. MAGL needs to be 
inhibited to reduce the accumulation of amyloid tangles and neurofibrils.  
A number of scientific investigations have been carried out by researchers to find 
out potent drug from medicinal herbs to treat neurological disorders. Generally Herbs 
which have anti-inflammatory and anti-oxidant activities may be used in the treatment of 
AD. Bacopa monnieri has exhibited better potential biological activities against Alzheimer 
than many of the suggested herbs. 
 Bacopa monnieri is widely known as water hyssop or jalbrahmi ,indigenous to the 
wetlands of southern india Bacopa monnieri was previously mentioned in the Ayurvedic 
literatures such as Athar-Ved, Charaka Samhita and Susrutu samhita as Medhya rasayana 
to sharpen the intellect and mental deficits attenuation(Aguiar et al., 2013) It has been 
used as medicine for attenuation of cognitive decrements in ayurvedha. The active 
constituents of Bacopa monnieri are steroidal saponins namely bacoside A and B. But the 
identity of bacoside B remains unclear. Bacoside A is most Studied Constituent. The 
IUPAC name of Bacoside A is 3-(a-L-arabinopyranosyl)-O-b-D-glucopyranoside- 10, 20-
dihydroxy-16-keto-dammar-24-ene. 
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Table 1.1: Taxonomical Classification of Brahmi     
Kingdom Plantae 
Order  Lamiales 
Family  Plantaginaceae 
Genus Bacopa 
Species B. monnieri 
Bionomial name Bacopa monnieri(L.) Pennell 
 
Bacoside A is a mixture of four triglycosidic saponins, namely bacoside A3, 
bacopaside II, bacopasaponin C and the jujubogenin isomer of bacosaponin C (bacopaside 
X) (Deepak et al., 2005). The structure of Bacoside A has been shown in figure 1.2 
Bacoside A, have been considered to be the main bioactive constituents responsible for the 
cognitive effects of B. monnieri.  
 
Fig 1.1: Bacopa monnieri 
 
Fig 1.2: Structure of Bacoside A 
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The amount of Bacoside A present in the plant is only 0.2 %. But the importance 
of the Bacoside A is high. Plant tissue culture techniques would be useful to enhance the 
herbal drug production. (Tejavathi and Shailaja.,1999). Elicitation is a process by which 
the production of important metabolites could be stimulated by the treatment of small 
amounts of chemicals or biological molecules (Brooks and Watson., 1986). Elicitors are 
stimuli from external source which capable of prompting the immune response of the plant 
which favours the accumulation of specific Secondary metabolite. 
This project deals with the in silico analysis for drug like activities of Bacoside A 
and its enhanced production in suspension cultures of Bacopa monnieri by the influence of 
elicitors. The drug like activities were analysed by molecular docking and ADMET 
predictor.Plant calluses were induced with the different concentration of Auxins and 
Cytokinins namely IAA, NAA & BAP. Induced calluses were inoculated in suspension 
cultures under optimised condition for mass production. The suspension cultures of 
B.monnieriwere induced with the different elicitor for the production the Bacoside A. The 
antioxidant potential of the callus was analysed by in vitro analyses. 
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CHAPTER 2 
OBJECTIVES 
 Selection of Plants and In Silico analyses of the Phytodrugs 
 Standardisation of callus induction with varying concentrations of Auxins 
(NAA,IAA)and Cytokinins (BAP) 
 Preparation of suspension culture and Elicitation 
 Estimation of Bacoside A by HPLC 
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CHAPTER 3 
LITERATURE REVIEW 
3.1 ALZHEIMER DISEASE 
Alzheimer‘s disease (AD) is a neurological disorder which destroys the memory 
and thinking skills gradually. Alzheimer‘s disease (AD) is named after German physician 
Aloes Alzheimer, who first described it in 1906 (Alzheimer's disease fact sheet). It is the 
most common form of dementia in older people. The severity of Alzheimer has been 
linked with the memory loss which is a cholinergic shortage (Bierer et al., 1995; 
Collerton., 1986; Giacobini., 1990). 
Approaches to enhance cognitive function in Alzheimer have included elongating 
the availability of acetylcholine (ACh) by the inhibition of ACh hydrolysis by 
acetylcholinesterase (AChE) enzyme., and reduction of Amyloid fibrillary tangles by 
inhibiting the enzyme MAGL. 
Monoacylglycerol lipase (MAGL) is the enzyme which metabolizing the 
endocannabinoid 2-arachidonoylglycerol to Arachidonic acid (AA) in the brain. Chen et 
al.,(2012) reported that the inactivation of MAGL strongly suppressed production and 
accumulation of beta amyloid (Ab) allied with reduced expression of BACE1 enzyme. 
The synthetic drugs such as Donepezil, Rivastigmine and Galantamine are used as 
AChE inhibitors  in Europe (Howes et al. 2003). 
An important approach for treating AD is the inhibition of acetylcholinesterase 
(AChE) and Monoacylglycerol lipase. A number of scientific research have been carried 
out on medicinal herbs. Herbs have anti-inflammatory and anti-oxidant activities that may 
be used in the treatment of AD. 
3.2 SELECTION OF PLANT 
3.2.1 Centella asiatica L. 
The essential oil extracted from C. asiatica leaf comprises of monoterpenes , such 
as bornyl acetate, α-pinene, β pinene and γ-terpinene which were reported to inhibit AChE 
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(Perry et al., 2000). These findings were suggesting that C. asiatica may be appropriate to 
treat Alzheimer and it may also influence cognitive function. 
3.2.2 Curcuma longa L. 
Many researches have concentrated on curcumin, a curcuminoid from rhizomes of 
C.longa. In vivo following oral administration of Curcumin against ethanol-induced brain 
injury was studied by Rajakrishnan et al., (1999). Results were showing that Curcumin 
could be neuroprotective which was related to a reduction in lipid peroxide levels and 
enhancement of glutathione in rat brain. 
3.2.3 Galanthus nivalis L. 
Galanthus nivalis was used conventionally in Bulgaria and Turkey for cognitive 
treatment. Galantamine, an Amaryllidaceae alkaloid from Galanthus nivalis L. is known 
for its potential against AChE (Mukherjee et al., 2007). Galantamine was reported for its 
inhibitory activity on AChE than butyrylcholinesterase. It is licensed for Alzheimer 
treatment in Eurpean countries (Lopez et al., 2002). It is modulating nicotinic receptors 
allosterically independent of inhibition of AChE. One of its derivative compounds was 
more active than galantamine on the inhibition of cholinesterase. Other Amaryllidaceae 
alkaloids such as assoanine, 11-hydroxygalantamine, oxoassoanine, sanguinine and 
epinorgalantamine have also been reported for their AChE inhibitory activity (Lopez et 
al., 2002). 
3.2.4 Huperzia serrata 
Huperzine A, is the compound isolated from Huperzia serrata from 
Lycopodiaceae family. Huperzine A and B are lycopodium alkaloids which could inhibit 
AChE in vitro and in vivo (Ashani et al., 1992; Laganie`re et al., 1991).These 
observations suggest Huperzine A has clinical potential in Alzheimer treatment. 
Huperzine A was found to be neuroprotective against Beta-amyloid fragment 25–53 (Xiao 
et al., 1999). It was also reported for oxygen-glucose deprivation by Zhou et al.,2001b and 
free radical induced cytotoxicity by Xiao et al. in 1999 
3.2.5 Salvia species 
The extracts of Salvia officinalis and Salvia lavandulifolia were reported to inhibit 
human AChE and butyrylcholinesterase in vitro. 1,8-Cineole was the most potent 
component in AChE inhibition (savelev et al.,2003). 
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3.2.6 Hypericum perforatum 
HP showed inhibition of the neuronal reuptake of 5-HT, norepinephrine, GABA, 
and L-glutamate. It also exhibited enhanced neurotransmitter sensitivity (Butterweck., 
2003).  
3.2.7 Polygala tenuifolia 
Root extracts of P. tenuifolia have been exhibited to reverse the effects of has been 
shown to be induced by Scopolamine in rats. It was reported as neuroprotective against 
toxic metabolites of APP in vitro. It showed dose dependent inhibition of AChE in vitro 
(Park et al.,2002). Sinapinic acid, a  derivative of cinnamic acid, is found in root extract of 
P.tenuifolia and It has been showed to increase ChAT activity in brain-lesioned rats (Yabe 
et al., 1997).  
3.2.8 Ginko biloba 
EGb 761, the extract of G. biloba was showing effects against cognitive 
dysfunction. Desirable effects were observed on neuronal cell metabolism and cerebral 
circulation (Loffler et al., 2001). EGb 761 was found to be neuroprotective against beta-
amyloid and toxicity induced by NO in vitro (Bastianetto et al., 2000a,b). The number of 
researches in vitro and in vivo showed that G. biloba having several activities related to 
Alzheimer treatment (Howes et al.,2003). 
3.2.9 Bacopa monnieri 
Bacopa monnieri is an indigenous plant of Indian subcontinent which has been 
used for weakening of cognitive decrements. Bacosides A and Bacosides B are the 
steroidal saponins which are the potent constituents of B.monnieri. The extracts of 
B.monnieri have reported to decrease beta amyloid levels in transgenic Alzheimer mice 
models (Holcomb et al., 2006). The extract of Bacopa monnieri at the dose of 40 mg/kg 
orally increased cholinergic neurons density significantly in hippocampus (Uabundit et al., 
2010). The phytoconstituent Bacoside A and B of Bacopa monneiri have been found to 
show better docking potential on MAGL than many other suggested drugs with a highest 
docking score of -6.845 (Shrutika et al., 2013). 
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3.3 BIOLOGICAL ACTIVITIES OF B.monnieri 
Table 3.1 Biological Activities of B. monnieri 
Activity Effects of B.monnieri Reference 
SOD and GSR 
enhancement 
Bacoside A administration improved the activity 
of GSR and SOD in the brains of cigarette 
smoke exposed rats.it restored the levels of 
selenium and zinc in brain in which the both 
were reduced by cigarette snmoke. 
Anbarasi  
et al,2006 
Choline acetyl 
transferase 
Activation 
Investigator studies the neuroprectection by 
Bacoside on Acetyl choline level. He 
hypothesised that the mechanism was not AChE 
inhibiton but the choline acetyl tranferase 
activation on maintaining Ach levels. 
Rastogi al., 2012 
Anti- Alzheimeric 
activity 
The extracts of B.monnieri exhibited vital effects 
on β-amyloid inhibition and dissociation of 
preformed fibrils. 
Mathew and 
Subramanian., 
2012 
AChE inhibitory 
activity 
B.monnieri extracts showed β-amyloid 
neurotoxicity protection and potential inhibitory 
activity against AChE. 
Limpeanchob et 
al., 2008 
CBF and 
Vasodilation 
B.monnieri extract exhibited  around 25% 
enhanced Cerebral Blood Flow in rat model  
Kamkaew et al. 
2013 
Antioxidant 
activity 
Brahmi extracted showed a significant 
antioxidant activity in many of the reported 
investigaytions 
Sumathy et 
al.,2001; Russo 
et al.,2003 
 
3.4 IN SILICO STUDIES ON BACOPA MONNIERI 
 Ramasamy et al, 2015 have reported an in silico study of Bacosides. They have 
used Discovery Studio 4.0 and ADMET predictor for the study of Druglikeness and 
toxicity. The reported the In vitro Assay for AChE inhibition Activity. The results 
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suggested the aglycones were having more binding potential than the Bacosides towards 
Target.  
Ravel and Jency, 2013 reported docking studies of various phytochemicals 
suggested for the treatment of Alzheimer. They used MAGL (Monoacyl glyceride Lipase) 
as target. Their results showed that Bacosides were having high docking scores than other 
phytochemicals 
3.5 IN VITRO CULTURES OF BACOPA MONNIERI 
Talukdar (2014) reported the biosynthesis of bacoside A in the callus cultures of 
Bacopa monnieri. He has used the Auxins IAA , NAA, 2,4 D for the induction of callus. 
Lower concentrations of NAA yielded high callus induction than higher concentration. 
The best callus induction observed in high concentration of 2,4 D. 
Vijayakumar et al., (2010) reported the in vitro propagation of Bacopa monnieri. 
Induction of callus was achieved in two weeks with NAA (0.5mg/l) and TDZ (0.25 mg/l). 
Further root induction and shoot induction was achieved by various combinations of 
Auxins and Cytokinins.  
Using in vitro cell suspension cultures of B. monnieri, 5-6 fold well grown over 40 
d, Rahman et al., (2002) have recorded up to 1 g/100 g dry weight of bacoside. An 
increase in total saponin bacoside content of 166% obtained from suspension culture 
established from callus biomass was reported by Monica et al. (2013). 
Subashri et al., (2014) reported the in vitro regeneration of Bacopa monnieri.The 
induction of multiple shoots from nodalsegments were highest in MS medium 
supplemented with 1.0 mg/l BA,1.0mg/l TDZ and 4.92mg/l 2ip. 
Mehta et al., (2012) reported the high frequency shoot regeneration and callus 
induction. Auxin 2,4 D and cytokinin BAP and Kinetin were used for both in this 
study.Leaf petiole explants were used forthe purpose of callus induction. Best growth was 
observed in MS medium supplemented with 0.25 mg/l 2, 4-D+ 0.5mg/l Kn and 0.25 mg/l 
2,4-D+ 0.1mg/l BAP. 
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3.6 ELICITATION OF BACOSIDE A 
 An elicitor is a substance which, induce or improves the biological synthesis of 
specific compounds in the living cell while it was supplemented in minimal concentration. 
Elicitation is the stimulated or improved biosynthesis of metabolites due to addition of 
small amounts of elicitor molecules (Radman et al.,2003). Elicitors can be classified on 
the basis of their ‗nature‘ like abiotic elicitors or biotic elicitors, or on the basis their 
‗origin‘ like exogenous elicitors and endogenous elicitors.  
Abiotic elicitors are the substances of non-biological origin, predominantly 
inorganic salts, and physical factors. Biotic elicitors are constituents with biological source 
which include glycoproteins, chitin, glucans and polysaccharides from plant cell walls 
such as pectin and cellulose. Important parameters for elicitation are elicitor concentration, 
exposure time and age of culture (Namdeo., 2007). 
Parale and Nikam (2009) reported the influence of biotic elicitors on the 
production of Bacoside A. Fungal elicitors Pencilliumnotatum, Rhizopus Stolonifer, 
Coriolusvercicolor, Mucor sp. and Saccharomyces cerevisae were used influence or this 
study in shoot cultures. The most significant elicitation was observed under the influence 
of Saccharomyces cerevisae and Mucor sp. Rest of the fungal elicitors did not make 
significant effects. 
Shrama et al., (2014) reported the influence of abiotic elictors for enhanced 
production of Bacoside A. this study reported the effect of CuSO4, Jasmonic acid and 
Salicylic acid. Enhanced Bacoside production was observed at 45 mg/l CuSO4 which 
yielded 1.42 fold higher than the control cultures in 9 days of exposure. Salicylic acid 
enhanced the production of Bacoside A to 1.32 fold higher than control at low 
concentration. Bacoside Accumulation decreased with the increase of Salicylic acid 
concentration. JA at a concentration of 1.0 mg/l significantly induced 3.08-fold higher 
yield of Bacoside A than control culture. 
Largia et al., (2015) reported the influence of Methyl jasmonate and Salicylic acid 
synergism on Bacoside production in shoot cultures. Different concentrations of MJ , SA 
and MJ+SJ was used for elicitation. The highest enhancement was obtained at the 
synergistic effect of 25µM SA+ 25µM MJ. The mixture of elicitors influence more than 
the single elicitor. 
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Ahmed et al (2014) reported a novel elicitor. ZnSO4 was supplemented with MS 
media for elicitation.  At 600µM of ZnSO4 the elicitation observed qualitatively. The 
amount of Bacoside was not quantified. 
3.7 ESTIMATION OF BACOSIDE A BY HPLC 
 HPLC conditions mentioned in Ayurvedic Pharmacopoeia of India for Bacoside 
estimation is slightly differing from British Pharmacopoeia. Researchers followed the both 
conditions. Mobile phase only differs.C18 column is widely used. The detection 
wavelength is 205 nm. Flow rate 1.5 ml/ min at temperature 30ºC. 
 API suggests the gradient of Acetonitrile and 0.05% ortho phosphoric acid ( pH 
2.8) at the ratio of 40:60 as mobile phase. Deepk et al., (2005) followed this method. 
 BP suggests that the mixture of acetonitrile and 0.71% w/v anhydrous sodium 
sulphate, previously adjusted to pH 2.3 with sulphuric acid at the ratio of 31.5:68.5 as 
mobile phase. Murthy et al., (2006) followed this protocol. 
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CHAPTER 4 
MATERIALS AND METHODS 
4.1 MOLECULAR DOCKING 
AUTODOCK VINA 1.5.6 was the software used for molecular docking and 
PYMOL-v.1.8.2.0 was used for visualisation of Docking results. The enzymes 
Acetylcholinesterase and Monoacylglyceride Lipase were used as receptors for this study. 
Six phytochemicals namely Alpha solanin, Bacoside A, Galantamine, Huperzine A, 
Huperzine B and limonene and one synthetic drug donepezil were used as ligand for 
docking study.  
Molecular docking procedure contains following steps. 
Receptor preparation: The structures of AChE and MAGL were downloaded in .pdb 
format from PDB site. The receptor molecules were loaded in AUTODOCK vina 
Software. The water molecules were removed from receptor molecules and the polar 
Hydrogen molecules were added to receptors. Then the prepared receptors were saved in 
.pdbqt format. The GRID box was assigned to the receptor. 
Ligand Preparation: Ligand molecule structures were downloaded from DRUGBANK 
and PubChem Sites. Ligands were loaded in AUTODOCK vina Software. The torsions 
were chosen for the ligand. And the output ligands were saved in the format of .pdbqt. 
Docking of ligand and receptor: Configuration file was created with the information of 
Receptor , Ligand and Grid box dimensions. Docking of ligand and receptor was run 
through AUTODOCK vina by using the command ―vina.exe –config conf.txt –log log.txt‖ 
in command panel. The results would be produced in terms of Binding energy. The lower 
value of binding energy is the positive indication of energy. 
Visualisation of Docking results :Output files would be created in .pdbqt format. These 
files were visualised in PYMOL viewer. The receptor molecules were opened in PYMOL 
and the docking positions of ligands were visualised.   
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4.2 DRUG-LIKENESS AND TOXICITY 
The chosen ligand molecule Bacoside A structure was downloaded from PubChem 
site and it was saved in the format of .mol. The molecular properties and the bioactivity 
scores were calculated by the online tool viz ‗molinspiration‘. The molecule in the format 
of SMILES was given as input in the ‗molinspiration‘ tool. Then it was run for calcution 
and displayed the results of molecular properties and the bioactivity scores of Bacoside A. 
PROTOX is the online toxicity predictor tool. The structure of Bacoside A was 
obtained from the PubChem which was linked with Ptotox toxicity predictor. The 
structure was given as input in the predictor and the calculated results were displayed. The 
toxicity results were saved and analysed for the properties of the molecule. 
4.3 SELECTION OF PLANT AND COMPOUND 
The plants with the potential for the treatment of Alzheimer were studied through 
literature. Many of the plants were reported for their ability to be a Alzheimer drug. But 
only few of the phytocompounds from some plants are proved that they are suitable drug 
for Alzheimer such as Bacoside A and Bacoside B from Bacopa monnieri and huperzine 
from Huperzia serreta. Ginko biloba is most widely reported plant with anti alzheimeric 
potential. Ginko biloba and Huperzia serreta are chinese herbs. Bacopa monnieri is Indian 
herband easily available. 
Bacopa monnieri is plant which has been chosen for our research study.  Bacoside 
A, a well-known herbal drug for Alzheimer is the compound to be produced in this 
project. Molecular docking results were the supporting documents behind the choice if 
Bacoside A. 
4.3.1 COLLECTION OF PLANT 
 Bacopa monnieri is widely available in Rourkela. It was collected from Saya 
Pharma Chem . The high yielding variety CIM-Jagriti of Brahmi was procured from 
CSIR-CIMAP, Lucknow. 
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4.4 CALLUS INDUCTION 
4.4.1 EXPLANT STERILISATION AND PREPARATION 
The plant parts were washed in running tap water for 30 minutes to remove the 
muds and dirts.3-5 drops of tween 20 was added in 100ml of distilled water and it was 
shaken vigorously   The excised plant parts were soaked in the detergent for 15 minutes. 
After that it was washed thoroughly in tap water. After the removal of detergents the 
explants were washed with sterile distilled water for 3-4 times. The procedures after this 
step was done in sterile conditions. Then explants are dipped in 70% ethanol for 30 
seconds. Then they immersed in 1.5% sodium hypochlorite solution for 5-8 minutes. Then 
it is washed with distilled water for 5 times. The washed explants were kept on sterile 
tissue paper to absorb the moisture. Sterilised plant parts are cut into small pieces in 
aseptic condition. The standard procedures were followed as mentioned by (De, 1997).  
4.4.2 INDUCTION OF CALLUS 
The MS medium solidified with agar was used for callus induction. The MS media 
is supplemented with different concentrations of Auxins namely IAA, NAA and Cytokinin 
BAP as mentioned in the table 5.3 at pH 5.8. Auxins only can induce the callus. Then the 
explants were inoculated in the sterilised MS solid media aseptically. The cultures were 
maintained at 24 ±2ºC. Friable callus is desirable for suspension cultures.   
4.5 SUSPENSION CULTURE PREPARATION 
The concentration of specific Auxin and Cytokinin which provide efficient callus 
induction is observed. 0.5 mg/l NAA and 0.1mg/l of BAP were supplemented in 
suspension cultures which is MS liquid media. Wet weight 500 µg of the friable calluses 
were inoculated in suspension culture of 100 ml. The culture is kept at 110 rpm in shaking 
incubator with 16 hours light and 8 hours dark condition for 20 days. Once the suspension 
culture was formed then it was sub cultured.  5 ml of Suspension culture was inoculated in 
100 ml of sterilised MS liquid media. 
The optimised parameters that influence the suspension culture are collected from 
literature. Most influencing parameter among the Sucrose, Phosphate, inoculum size and 
Nitrate to Ammonium ratio was determined by Plackett Burman Design. With the 
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optimised parameter such as carbon source, nitrogen source, temperature and pH were 
used for mass production and elicitation production in suspension cultures. 
4.5.1 PLACKETT BURMAN DESIGN 
Sucrose concentration, Phosphate concentration, Inoculum size and Nitrate to 
Ammonium ratio were the parameters which were chosen for Placket Burman Design. 
Each parameter was tested as two concentrations such as High and Low concentrations as 
mentioned in Table 4.1. 
Table 4.1 Plackett Burman Factor value Assumptions 
FACTOR HIGH VALUE LOW VALUE 
Sucrose 60 g/l 30g/l 
NO3
-
/NH4
+
 Ratio 5:1 2:1 
Phosphate 2 mM 1.2 mM 
Inoculum Size 1 g/l 0.2 g/l 
 
Eight experiments were formulated and the Dry cell weight of the biomass was the 
response. The design Expert version 5.0.9 was the software used for the development of 
design. The cultures with test proportion of media were prepared for 50 ml and they were 
incubated at 27 ºC in shaker incubator for 12 days at 110 rpm. Dry cell weight was 
estimated after12 days.      
4.6 ELICITATION AND ESTIMATION OF BACOSIDE A 
4.6.1 ELICITOR PREPARATION AND ELICITATION 
Elicitors Chitosan and CuSO4were used for elicitation experiments. Chitosan is 
dissolved in diluted 1% acetic acid. CuSO4 was dissolved in water. Casein hydrolysate 
was dissolved in distilled water. The three elicitors were used in the concentrations of 50 
µg/ l, 100 µg/ l and 200 µg/ l. Different concentrations of these elicitors were 
supplemented with the 50 ml of Suspension culture. The culture is maintained with 16 
hours light and 8 hours dark condition at 110 rpm. The exposure time for the Elicition 
process is 6-9 days. After the completion of elicitation period the influence of elicitor are 
analysed by the quantification of Bacoside A by HPLC. Accumulated biomass is collected 
by centrifugation. It was dried at 60ºC .Methanol was added to it and ultrasonicated for 8 
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minutes at 20kHz. The it was centrifuged and the collected supernatant was used for 
HPLC analysis. 
4.6.2 ESTIMATION OF BACOSIDE A 
Methanolic extracts of fresh plant, control callus and elicitor treated callus are used 
for the estimation of the amount of Bacoside A. Plants and  callus were dried at 50°C. 
Then 500mg of dried plant and 200 mg of dried callus were finely grinded with mortar 
and pestle. 10 ml of methanol was added to each powdered samples and those were 
ultrasonicated for 8 minutes at 20kHz. The collected supernatant after the centrifugation 
was used for HPLC analyses. HPLC standard was prepared with methanol at the 
concentrations of 1 mg/ml. HPLC conditions are followed as the procedure mentioned in 
Indian Herbal Pharmacopoeia with slight modifications (Deepak et al., 2005). C18 column 
was used. The mobile phase used was the gradient of Acetonitrile and 0.05M Sodium 
phosphate whose pH was adjusted to 2.8 with ortho phosphoric acid as mentioned in Table 
4.2. The flow rate is 1.0 ml/min. the detection wavelength is 205 nm.  
Table 4.2 Mobile phase gradient ratio 
TIME  
(minutes) 
BUFFER at pH 2.8 
 (% V/V) 
ACETONITRILE  
(% V/V) 
0 70 30 
25 60 40 
35 40 60 
36 70 30 
45 70 30 
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CHAPTER 5 
RESULTS AND DISCUSSIONS 
5.1 MOLECULAR DOCKING 
The docking results were showed in table 5.1 in which Acetylcholine esterase was used as 
receptor. Table 5.2 shows the results of phytochemicals docked with the receptor 
Monoacyl Glyceride Lipase. 
Table 5.1 Docking results for the target AChE 
LIGAND SOURCE  BINDING ENERGY (kcal/mol) 
Alpha solanine Solanum tuberosum -16.1 
Bacoside A Bacopa monnieri -20.1 
Donepezil Synthetic drug -8.6 
Galantamine Galanthus nivalis L. -9.3 
Huperzine  A Huperzia serrate -9.8 
Huperzine B Huperzia serrate -9.7 
Limonene Citrus fruits -11.8 
Target : Acetylcholinesterase 
Table 5.2 Docking results for the target MAGL 
LIGAND SOURCE  BINDING ENERGY (kcal/mol) 
Alpha solanine Solanum tuberosum -11.6 
Bacoside A Bacopa monnieri -12.7 
Donepezil Synthetic drug -6.6 
Galantamine Galanthus nivalis L. -7.5 
Huperzine  A Huperzia serrate -7.7 
Huperzine B Huperzia serrate -7.8 
Limonene Citrus fruits -10.1 
Target : Monoacyl Glyceride Lipase 
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The figure 5.1  shows the docking position of ligand with receptor AChE at their best 
torsion  whose RMSD value was minimum.     
 
Fig 5.1 Docking of ligands with Target AChE  (A-Alpha solanine, B-Bacoside A, C-
Donepezil, D-Galantamine, E-Huperzine A, F-Huperzine B, G-Limonene) 
Figure 5.2 shows the docking position of ligand at its best torsion with MAGL receptor 
 
Fig 5.2 Docking of ligands with Target MAGL (A-Alpha solanine, B-Bacoside A, C-
Donepezil, D-Galantamine, E-Huperzine A, F-Huperzine B, G-Limonene) 
For the treatment of Alzheimer AChE and MAGL are the target receptor. Six 
phytochemicals were docked with these targets. A synthetic drug Donepezil also docked 
 19 | P a g e  
 
with those receptor. Among these ligands Bacoside A is showing high affinity towards 
both the receptors since it is having very low binding energy. These results give us 
positive hope and are being a supporting document for the suggestion of Bacoside A to be 
Alzheimer drug. 
5.2 DRUG-LIKENESS AND TOXICITY 
The molecular properties and bioactivity scores of Bacoside A were calculated by 
the online predictor tool namely ―molinspiration‖. The results have been showed in figure 
5.3 and 5.4 
 
Fig 5.3 Molecular properties of Bacoside A 
 
Fig 5.4 Bioactivity Scores of Bacoside A 
The bioactivity scores of bacoside A were considerable and it was showing a good drug-
likeness properties. These results are showing that most of the molecular properties of 
Bcoside A are satisfying the Lipinski's rule of five. The molecular weight of the 
compound is only likely to be violating the rule. 
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Fig 5.5 Toxicity prediction results of Bacoside A 
Toxicity of Bacoside A was predicted by the toxicity predictor tool ―protox‖. The 
results showed that class 4 toxicity was observed. Class 4 toxicity was not harmful. In 
silico analyses are showing positive results for Bacoside A to be Drug molecule. 
Numerous in vitro studies proved its anti alzheimeric potential. So such important plant 
metabolite should be produced more for its increasing requirements. 
5.3 SELECTION OF PLANT 
From the results of Molecular docking and the literature proofs Bacopa monnieri 
was selected for the project and Bacoside A was the target molecule in this report work to 
be produced in the callus cultures.   
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5.4 CALLUS INDUCTION 
5.4.1 CALLUS INDUCTION FROM FIELD GROWN EXPLANT 
Leaves were used as explants. Different concentrations of Auxins were used alone 
and in combination with Cytokinin in MS agar Media. The Hormones used, their 
concentration and the observations were mentioned in the table 5.3. 
Tables 5.3 Standardisation of Callus induction 
HORMONE mg/L  
Callus 
induction 
 
Observation IAA NAA BAP 
0.25 - - - Root induction 
0.50 - - - Root induction with multiple shoot induction 
1.00 - - - Root induction with multiple shoot induction 
0.25 - 0.10 + Root induction with multiple shoot induction 
Callus initiation also observed 
- 0.25 - ++ Callus induction with root formation 
- 0.50 - ++ Callus induction with root formation 
- 1.00 - + Callus initiation 
- 0.25 0.10 ++ Callus induction with less root formation 
- : no induction    +  : Poor callus initiation  ++ :Good callus initiation 
 
Fine calluses were induced by the use of auxin NAA at the concentration 0.25 
mg/L (Fig 6.6) and 0.50 mg/L (Fig 5.7). Some root formation also observed with the 
callus. To inhibit the root induction the cytokinin BAP at the concentration 0.10 mg/L was 
added with auxins.  
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Fig 5.6 Induced callus at 0.25mg/L of NAA   
 
Fig 5.7 :Induced callus at 0.50mg/L of NAA  
Usage of auxin IAA has no significant effect on callus induction. It induced root induction 
with multiple shoot from leaf explant (Fig 5.8). If the inoculated culture maintained at 
dark condition there was no formation of multiple shoots (Fig5.9).. But IAA was not much 
effective in callus induction of Bacopa monnieri  
 
 Fig 5.8  Multiple shoot and root formation 
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Fig 5.9  Effect of IAA in dark condition 
5.4.2 PREPARATION OF IN VITRO PLANT 
 To avoid the threats of contamination and to increase the explant purity in vitro 
grown plant is the good option. The combination of Auxin and cytokinin at the 
concentration of 1.0 mg/L IAA and 0.1 mg/L BAP was used in MS media for in vitro 
plant preparation. Root induction (Fig 5.10) and the Elongation (Fig 5.11) of shoots were 
observed with rapid growth.  
                                                                 
                Fig 5.10 Root induction                                              Fig 5.11 In vitro plant 
5.4.3 CALLUS INDUCTION FROM IN VITRO GROWN EXPLANT 
 Callus induction from the field grown leaf explants experiment results shows that 
0.50 mg/L concentration of NAA is able to induce the fine callus. To avoid the root 
induction low concentration of cytokinin should be added. 
 Leaf and shoots from the in vitro grown plants were used as explants. The 
combination of 0.5 mg/L of NAA and 0.10 mg/L of BAP is supplemented with MS agar 
media at pH 5.8. The explants were sliced from in vitro grown plant and they were 
inoculated aseptically in media. Fine callus was induced from leaf explants. Callus 
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initiation was observed at 15
th
 day from inoculation. Images of callus induced from at 
different time interval were shown in Figure 5.12,5.13 and 5.14. callus from the shoot 
explant was shown in figure 5.15. shoot explant was not much efficient in callus induction 
           
Figure 5.12  callus induced from in vitro grown Leaf explant (14 days old)  
 
Figure 5.13 14 Days old Callus induced from in vitro grown Leaf explant at varying 
hormonal concentration [ A) 0.25 mg/l NAA B) 0.50 mg/l NAA C) 1.0 mg/l NAA 
D)0.5mg/l NAA+0.1 mg/l BAP] 
 
Figure 5.14 21 Days old Callus induced from in vitro grown Leaf explant at varying 
hormonal concentration [ A) 0.25 mg/l NAA B) 0.50 mg/l NAA C) 1.0 mg/l NAA 
D)0.5mg/l NAA+0.1 mg/l BAP] 
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Figure 5.15 Callus induced from in vitro grown shoot explant (23 days old) 
Table 5.4 Callus growth by the influence of NAA and BAP 
Concentration of 
hormones (mg/l) 
Dry weight of the callus in 
milligrams 
Growth Rate of callus 
Day
-1
 
NAA BAP 14 days old 21 Days  
0.25 - 6.5±0.6 14.8±0.8 0.182418 
0.50 - 21.1±2.3 32.4±1.1 0.076506 
1.00 - 1.4±0.2 6.8±0.6 0.55102 
0.50 0.10 11.1±0.4 17.9±0.4 0.087516 
 
 
Fig 5.16 Comparison of callus growth at 14 and 21 days 
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The dry weights of callus induced from varying concentrations of hormones at 
different time interval were mentioned in table 5.4 and the comparative bar graph was 
shown in figure 5.16. 
5.5 SUSPENSION CULTURES 
5.5.1 PLACKETT BURMAN DESIGN 
 The results of placket Burman design showed the most influencing parameter of 
suspension culture for the growth of callus. The results were shown in the table 5.5. 
Table 5.5 Plackett Burman Experiment results 
Experiment 
number 
Factor A 
NO3/NH4 
RATIO 
Factor B 
Sucrose 
g/l 
Factor C 
Phosphate 
mM 
Factor D 
Inoculum 
g/l 
Response 
Dry cell 
weight(g/l) 
1 05:01 30 1.2 1 0.242 
2 02:01 60 2 0.2 0.14 
3 02:01 60 1.2 1 0.208 
4 05:01 60 1.2 0.2 0.028 
5 05:01 60 2 1 0.2 
6 02:01 30 1.2 0.2 0.064 
7 02:01 30 2 1 0.186 
8 05:01 30 2 0.2 0.018 
  
Table 5.6 The value of regression coefficient (t-value) from Plackett Burman 
experiments 
S.No Name Code t-value Priority of factor for 
affecting biomass 
1.  NO3/NH4 ratio A -0.42 - 
2.  Sucrose B 0.25 2 
3.  Phosphate C 7.46 X 10-3 3 
4.  Inoculum D 4.87 1 
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Plackett Burman experiment result showed that inoculum size and the sucrose 
concentrations were the major factors affecting the biomass production. It has indicated by 
the t- value.(Table5.6). the Least affecting parameters for biomass production was nitrate 
concentration since the t-value was negative. These effects can be understood by half 
normal plot in figure 5.16. Choi et al.,1994 reported that Saponin production increased 
with sucrose levels of upto 60g/l. they also reported inhibition of cell growth at 70 g/l 
concentration of sucrose.  
 
Fig 5.17 Half Normal Plot 
 
5.6 ELICITATION AND ESTIMATION OF BACOSIDE A 
Suspension culture was treated with three elicitors namely Copper sulphate, 
Chitosan and Casein Hydrolysate at varying concentrations of 50µg/l, 100µg/l and 
200µg/l. There was no extractable amount of yield was obtained. So the amount of 
Bacoside produced could not be estimated by HPLC. The standard HPLC graph of 
Bacoside A at concentration of 100µg/ml was shown in figure 5.17. 
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Fig 5.18 Standard HPLC graph of Bacoside A 
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CHAPTER 6 
CONCLUSION 
The In Silico studies are showing the potential of Bacoside A to be a drug for 
Alzheimer. The docking potential of Bacoside A on AChE and MAGL is comparatively 
higher than any other reported phytochemicals. Bacoside A is having binding energy of -
20.1 and -12.7 on the targets AChE and MAGL respectively. It has been calculated by  
Molecular Docking using AUTODOC vina software tool.  
From the results of Toxicity predictor, we can come to a positive conclusion that 
Bacoside A not much toxic. It is coming under Class 4 toxicity which is practically non- 
toxic. The druglikeness of Bacoside A was measured by bioactivity score using 
molinspiration tool. 
The hormone concentrations were standardised for better callus induction.The 0.50 
mg/l concentration ofNAA resulting in better callus induction than other concentrations. 
IAA was not showing significant callus inductions.To inhibit the root inductions small 
amount of cytokinins need to be added. 
The most influencing parameters for the production of biomass in suspension 
cultures were analysed by Plackett Burman design. Inoculum size and the sucrose 
concentrations were the most influencing factors. 
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